Open AccessLong-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid Carcinoma
Author(s) -
Philip M. Spanheimer,
Ian Ganly,
Joanne F. Chou,
Marinela Capanu,
Ronald Ghossein,
R. Michael Tuttle,
Richard J. Wong,
Ashok R. Shaha,
Brian R. Untch
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-07869-9
Subject(s) - medicine , cumulative incidence , surgical oncology , oncology , proportional hazards model , carcinoembryonic antigen , cohort , thyroid carcinoma , medullary thyroid cancer , survival analysis , incidence (geometry) , thyroid cancer , cancer , thyroid , physics , optics
Long-term outcomes after curative resection in patients with germline RET mutations and medullary thyroid cancer (MTC) are highly variable and mutation-specific oncologic outcomes are not well-described.